Soleno Therapeutics (SLNO) surges 33%+ premarket on Neurocrine’s $2.9B all-cash bid — April 6, 2026
Soleno Therapeutics (NASDAQ: SLNO) surged more than 33% in premarket trading on...
Soleno Therapeutics (NASDAQ: SLNO) surged more than 33% in premarket trading on...